Augmented expression of a myeloid-specific protein tyrosine kinase gene (hck) after macrophage activation

Journal of Experimental Medicine

Volumn 168, Issue 5, 1988, Pages 1801-1810

  Ziegler, Steven F ^a   Wilson, Christopher B ^b   Perlmutter, Roger M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROTEIN TYROSINE KINASE; RNA;

ADULT; BIOLOGICAL MODEL; CELL CULTURE; CYTOCHEMISTRY; GENE; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MYELOID ANTIGEN; NORMAL HUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTO ONCOGENE;

BLOTTING, NORTHERN; GENE EXPRESSION REGULATION; HUMAN; IMMUNOBLOTTING; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE PROTEINS; MULTIGENE FAMILY; PROTEIN-TYROSINE KINASE; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024269038     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.168.5.1801     Document Type: Article

References (45)

1. Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283.
2. Adams, D. O., and T.A. Hamilton. 1987. Molecular transductional mechanisms by which IFN-y and other signals regulate macrophage development. Immunol. Rev. 97:5.
3. Pace, J. L., S. W. Russell, B. A. Torres, H. M. Johnson, and P. W. Gray. 1983. Recombinant mouse y-interferon induces the priming step in macrophage activation for tumor cell killing. f. Immunol. 130:2011.
4. Straussmann, G., S. D. Somers, T A. Springer, D. O. Adams, and T A. Hamilton. 1986. Biochemical models of interferon-y-mediated macrophage activation: independent regulation oflymphocyte function associated antigen (LEA-1) and I-A antigen on murine peritoneal macrophages. Cell. Immunol. 97:110.
5. Kornbluth, R. S., and T S. Edington. 1986. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNFa-mediated cellular cytotoxicity by endotoxin. J Immunol. 137:2585.
6. Fenton, M. J., B. D. Clark, K. L. Collins, A. C. Webb, A. Rich, and P E. Auron. 1987. Transcriptional regulation of the human pro-interleukin-1R gene. j Immunol. 138:3972.
7. Fuhlbrigge, R. C., D. D. Chaplin, J. -M. Kiely, and E. L. Unanue. 1987. Regulatio n of interleukin-1 gene expression by adherence and lipopolysaccharide.J. Immunol. 138:3799.
8. Burchett, S. K., W. M. Weaver, J. A. Westall, A. Larsen, S. Kronheim, and C. B. Wilson. 1988. Regulatio n of tumor necrosis factor/cachectin and interleukin-1 secretion.J. Immunol. 140:3473.
9. Ruco, L. P., and M. S. Meltzer. 1978. Macrophage activation for tumor cytotoxicity:Development ofmacrophage cytotoxic activity requires completion of a sequence of shortlived intermediary reactions. J Immunol. 121:2035.
10. Pace, J. L., and S. W. Russell. 1981. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. J. Immunol. 126:1863.
11. Introna, M., T. A. Hamilton, R. Er. Kaufman, D. O. Adams, and R. C. Bast, Jr. 1986. Treatment of murine peritoneal macrophages with bacterial lipopolysaccharide alters the expression of c fos and c-myc oncogenes. J. Immunol. 137:2711.
12. Introna, M., R. C. Bast, Jr., C. S. Tannenbaum, T. A. Hamilton, and D. O. Adams. 1987. The effects of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages. J. Immunol. 138:3891.
13. Rettenmier, C. W., J. H. Chen, M. F Roussel, and C. J. Sherr. 1985. The product of the cfms proto-oncogene: A glycoprotein with associated tyrosine kinase activity. Science (Wash. DC). 228:320.
14. Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60-s" transforming ability by mutation ofits primary site of tyrosine phosphorylation. Cell. 49:65.
15. Piwnica-Worms, H., K. B. Saunders, T M. Roberts, A. E. Smith, and S. H. Cheng. 1987. Tyrosin e phosphorylation regulates the biochemical and biological properties of pp60'-s’. Cell. 49:75.
16. Cartwright, C. A., W. Eckhart, S. Simon, and P. L. Kaplan. 1987. Cell transformation by pp60'-" mutated in the carboxy-terminal regulatory domain. Cell. 49:83.
17. Marth, J. D., J. A. Cooper, C. S. King, S. F Ziegler, D. A. Tinker, R. W. Overall, E. G. Krebs, and R. M. Perlmutter. 1988. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56"k). Mol. Cell. Biol. 8:540.
18. Ziegler, S. F., J. D. Marth, D. B. Lewis, and R. M. Perlmutter. 1987. Novel proteintyrosine kinase (hck) expressed in cells of hematopoietic origin. Mol. Cell. Biol. 7:2276.
19. Quintrell, N., R. Lebo, H. Varmus, J. M. Bishop, M. J. Pettenati, M. M. LeBeau, M. O. Diaz, and J. D. Rowley. 1987. Identification ofa human gene (HCK) that encodes a protein tyrosine kinase and is expressed in hematopoietic cells. Mol. Cell. Biol. 7:2267.
20. Marth, J. D., D. B. Lewis, C. B. Wilson, M. E. Gearn, E. G. Krebs, and R. M. Perlmutter. 1987. Regulatio n of pp56"k during T-cell activation: functional implications for the srclike protein tyrosine kinases. EMBO (Eur. Mol. Biol. Organ.) j 6:2727.
21. Willman, C. L., C. C. Stewart, J. K. Griffith, and T B. Tomasi. 1987. Differential ex-pression and regulation of the c-src and cfgr protooncogenes in myelomonocytic cells. Proc. Natl. Acad. Sci. USA. 84:4480.
22. Wilson, C. B., and J. S. Remington. 1979. Effect s of monocytes from human neonates on lymphocyte transformation. Clin. Exp. Immunol. 36:511.
23. Johnson, W. D., B. Mei, and Z. A. Cohn. 1977. The separation, long-term cultivation and maturation of the human monocyte. J. Exp. Med. 146:1613.
24. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolatio n of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294.
25. Thomas, P. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 77:5201.
26. Palmiter, R. D., R. R. Behringer, C. J. Quaife, F. Maxwell, I. H. Maxwell, and R. L. Brinster. 1987. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell. 50:435.
27. Spindler, K. R., D. E. Rosser, and A. J. Berk. 1984. Analysis ofadenovirus transforming proteins from early regions lA and 1B with antisera to inducible fusion proteins produced in Escherichia coli. J. Virol. 49:132.
28. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 42:248.
29. Hammerstrom, J. 1979. Human macrophage differentiation in vivo and in vitro. Acta Pathol. Microbiol. Scand. 87:113.
30. Nakagawara, A., C. F. Nathan, and Z. A. Cohn. 1981. Hydrogene peroxide metabolism in human monocytes during differentiation in vitro. J Clin. Invest. 68:1243.
31. Matsushima, K., M. Taguchi, E. J. Kovacs, H. A. Young, and J. J. Oppenheim. 1986. Intracellular localization ofhuman monocyte associated interleukin 1 (IL-1) activity and release of biologically active IL-1 from monocytes by trypsin and plasmin. J Immunol. 136:2883.
32. Hunter, T. 1987. A thousand and one protein kinases. Cell. 50:823.
33. Hunter, T., andJ. A. Cooper. 1986. Protein tyrosine kinases. Annu. Rev. Biochem. 54:897.
34. Stahl, M. L., C. R. Ferenz, K. L. Kelleher, R. W. Kriz, andJ. L. Knopf. 1988. Sequence similarity ofphospholipase C with the non-catalytic domain region ofsrc. Nature (Loud.). 332:269.
35. Johnson, P J., P. M. Coussens, A. V. Danko, and D. Shalloway. 1985. Overexpressed pp60'-s’° can induce focus formation without complete transformation of NIH 3T3 cells. Mol. Cell. Biol. 5:1073.
36. Kawakami, T., S. S. Taylor; and K. C. Robbins. 1986. Isolation and oncogenic potential of a novel human src-like gene. Mol. Cell. Biol. 6:4195.
37. Brugge, J. S., P. C. Cotton, A. E. Queral, J. N. Barrett, D. Nonner, and R. W. Keane. 1985. Neurones express high levels of a structurally modified, activated form of pp60°-s". Nature (Loud.). 316:554.
38. Golden, A., S. P Nemeth, and J. S. Brugge. 1986. Blood platelets express high levels of the pp60°-1"-specific tyrosine kinase activity. Proc. Natl. Acad. Sci. USA. 83:852.
39. Marth, J. D., R. Peet, E.G. Krebs, and R. M. Perlmutter. 1985. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell. 43:393.
40. Perlmutter, R. M., R. Peet, J. D. Marth, D. B. Lewis, S. F. Ziegler, and C. B. Wilson. 1988. Conservatio n of function in the src gene family: the structure and expression of a human lymphocyte-specific protein-tyrosine kinase (lck). J Cell. Biochem. In press.
41. Fenton, M. J., M. W. Vermeulen, B. D. Clark, A. C. Webb, and P. E. Auron. 1988. Human pro-IL-10 gene expression in monocytec cells is regulated by two distinct pathways. J Immunol. 140:2267.
42. Stanley, E. R., L. J. Guilbert, R. J. Tushinski, and S. H. Bartelmez. 1983. CSF1-amononuclear phagocyte lineage-specific hematopoietic growth factor. f. Cell. Biochem. 21:151.
43. Wing, E. J., N. M. Ampel, A. Waheed, and R. K. Shadduck. 1985. Macrophage colonystimulating factor (M-CSF) enhances the capacity ofmurine macrophages to secrete oxygen reduction products. , J. Immunol. 135:2052.
44. Parsons, S. J., and C. E. Creutz. 1986. p60` -" activity detected in the chromaffin granule membrane. Biochem. Bio;6hys. Res. Commun. 134:736.
45. Azarnia, R., S. Reddy, T. E. Kmiecik, D. Shalloway, and W. R. Loewenstein. 1987. The cellular src gene product regulates junctional cell-to-cell communication. Science (Wash. DC). 239:398.